ComplySci Funding History & Investors

ComplySci has raised $131M across 3 funding rounds, most recently a $120M undisclosed-stage round in June 2021.

Last ComplySci funding round

$120M

Undisclosed stage · Jun 2021

Cumulative funding ComplySci raised

$131M

across 3 funding rounds

Key investors in ComplySci

  • Edison Partners
  • K1 Investment Management

ComplySci Overview

About ComplySci

New York-based ComplySci is a regulatory technology provider founded in 2003, serving over 1,400 clients including leading global financial institutions. The platform monitors employee personal trading, political donations, gifts, and outside business activities to detect conflicts of interest and ensure SEC and FINRA compliance through automated surveillance and reporting.


Founded

2003

HQ

United StatesNew York City, NY

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

ComplySci Funding History

ComplySci has raised a total of $131M across 3 funding rounds.

ComplySci's first fundraising round was a $8M Series A in January 2014. The most recent completed round was a $120M undisclosed-stage round in June 2021.

ComplySci funding rounds

ComplySci funding rounds
DateStageInvestorsRaisedDeal Summary
Jun 2021Undisclosed stageK1 Investment Management (lead)$120MComplySci, the leading provider of regulatory technology (RegTech) and compliance solutions for the financial services sector, received a growth capital investment of approximately $120 million from K1 Investment Management on June 10, 2021. The investment was described as a growth equity round, with K1 joining existing investors Vista Equity Partners and Edison Partners, who retained their stakes. ComplySci, founded in 2003 and operating as Compliance Science, serves broker-dealers, registered investment advisers, hedge funds, private equity firms, venture capital firms, and other financial services entities to identify and mitigate employee regulatory and compliance risks through software platforms. The capital was intended to support new and enhanced solutions for ComplySci's expanding customer base of over 1,400 clients, accelerate growth through product development, and pursue acquisitions. CEO Amy Kadomatsu highlighted the company's record financial performance in Q1 2021 as its strongest ever, underscoring momentum in the fintech compliance segment amid complex regulatory environments. K1's involvement was positioned to drive expansion opportunities in tech-empowered employee compliance. Post-investment, ComplySci expanded its board with additions like Stephen Marsh of Smarsh and Susan Theder of Advisor Group, reflecting growth momentum. The company continued aggressive expansion, acquiring RIA in a Box (previously backed by Aquiline Capital Partners, which had tripled its revenue), NRS, and illumis, building a robust portfolio of compliance, cybersecurity, and operational tools for wealth management. In 2022, ComplySci was recognized as 'Best New Solution Provider' by Private Equity Wire, following the K1 investment and acquisitions.
Jul 2016Seed-$3M-
Jan 2014Series AEdison Partners (lead)$8MComplySci (then Compliance Science, Inc.) received an $8.25M Series A investment from Edison Partners (then Edison Ventures) on January 8, 2014. This marked the company's initial outside capital, with Edison acquiring a minority ownership interest. The funding aimed to accelerate technology and product development, as well as expand sales and marketing efforts.

Who has invested in ComplySci?

2 investors have backed ComplySci across its funding rounds, including Edison Partners and K1 Investment Management.

Lead investors include K1 Investment Management and Edison Partners.


ComplySci Investors

Investors in ComplySci by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 2 ComplySci investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by ComplySci

ComplySci has acquired 3 companies to date.

Last acquisition by ComplySci was on December 9th 2021. ComplySci acquired RIA in a Box for undisclosed valuation.


Latest Acquisitions by ComplySci

RIA in a Box
illumis
National Regulatory Services
Description
RIA in a Box is a Cumming, Georgia-based SaaS provider offering compliance management software for registered investment advisers across the United States. The platform automates Form ADV filing, cybersecurity audits, and employee trading oversight for nearly 2,000 firms managing assets from USD 100 million to over USD 10 billion. Additional modules include CRM integration with Redtail and billing tied to custodial platforms like Schwab and Fidelity.
illumis is a data aggregation platform compiling public records from government databases and court filings. Located in Washington, D.C., the service equips finance, political, and media organizations with searchable archives for due diligence and investigations. Founded in 2018, illumis streamlines access to property, litigation, and corporate records across U.S. jurisdictions.
National Regulatory Services is a Melville-based compliance provider under Accuity serving broker-dealers, investment advisers and hedge funds. It offers RegTech software for Form ADV filings, annual reviews and cybersecurity audits alongside training programs accredited by FINRA.
HQ CountryUnited StatesUnited StatesUnited States
HQ City
New York City, NY
New York City, NY
Minneapolis, MN
Deal Date9 Dec 202118 Nov 202121 Oct 2021
Valuationundisclosed$18Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ComplySci acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by ComplySci

ComplySci has invested in 1 company to date.

Latest investment by ComplySci was on January 29th 2019. ComplySci invested in Bipsync in their $7M Series A round.


Latest Investments by ComplySci

Bipsync
Description
San Francisco-headquartered Bipsync is a research and workflow management platform for investment firms across asset classes and strategies. Founded in 2012, the company serves allocators from the largest institutions to emerging managers with tools for data aggregation, collaboration, and operational efficiency in a single system of record.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date29 Jan 2019
RoundSeries A
Raised$7M
InvestorsPFS; MoneyLion; GAIN Capital; BFS Capital; Franchise Group; FINTOP Capital; EdgeTrade; Predata; Edison Partners; Clearpool Group
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all ComplySci investments and their VC round multiples.

Start Free Trial

Common questions about ComplySci

When was ComplySci founded?ComplySci was founded in 2003.
Where is ComplySci headquartered?ComplySci is headquartered in New York City, NY, United States.
Is ComplySci publicly listed?No, ComplySci is a private, VC-backed company.
How much funding has ComplySci raised?ComplySci has raised $131M across 3 funding rounds.
What was ComplySci's last funding round?ComplySci's last funding round was a $120M undisclosed-stage round in June 2021, led by K1 Investment Management.
Who are ComplySci's investors?ComplySci's investors include K1 Investment Management and Edison Partners.
How many companies has ComplySci acquired?ComplySci has acquired 3 companies, including RIA in a Box, illumis and National Regulatory Services.
What was the largest acquisition by ComplySci?The $18M acquisition of illumis in November 2021 is the largest acquisition ComplySci has made to date.
How many companies has ComplySci invested in?ComplySci has invested in 1 company, including Bipsync.
What was ComplySci's last investment?In January 2019, ComplySci invested in Bipsync's $7M Series A alongside PFS, MoneyLion, GAIN Capital and 7 other investors.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial